Skip to main content
. 2009 May 23;14(12):1451–1458. doi: 10.1007/s10495-009-0359-1

Table 1.

Targeted cytoprotective genes and effects on renal cell apoptosis and nephropathy

Targeted genes in diabetic animal models Effects on diabetic renal cell apoptosis and nephropathy
Transgenic catalase mice Reduced albuminuria, glomerulosclerosis, interstitial fibrosis and tubular apoptosis [59, 60]
Catalase-deficient mice Kidneys are more prone to oxidative stress [61]
HO-1 gene transfer in mice or rats Reduced apoptosis and kidney injury [63]
HO-2-deficient mice Enhanced STZ-induced diabetic nephropathy, which could be restored by HO-1 gene transfer [64]
SOD transgenic mice Protection against diabetic nephropathy [68]
Thioredoxin-1 transgenic mice Diminished albuminuria and tubular apoptosis [67]
Peroxiredoxin-3 transgenic mice Protection against hyperglycemia and glucose intolerance and reduced fibroblast apoptosis by reducing mitochondrial H2O2 production [69]
Glutathione peroxidase-1-deficient mice No effects on T1DM-induced kidney injury [70]
Mice with a reduction of thrombo-modulin-dependent protein C activation Aggravated glomerular apoptosis and diabetic nephropathy [19, 56]
Mice expressing a hyper-activatable protein C mutation Protein C activation prevents glomerular apoptosis and diabetic nephropathy [19, 56]